F486-0691 Screening compound: 2-(4-fluorophenyl)-4-methyl-6-[5-(morpholine-4-carbonyl)-1,2,4-oxadiazol-3-yl]-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

F486-0691 Screening compound: 2-(4-fluorophenyl)-4-methyl-6-[5-(morpholine-4-carbonyl)-1,2,4-oxadiazol-3-yl]-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione
F486-0691 Screening compound: 2-(4-fluorophenyl)-4-methyl-6-[5-(morpholine-4-carbonyl)-1,2,4-oxadiazol-3-yl]-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound F486-0691
2-(4-fluorophenyl)-4-methyl-6-[5-(morpholine-4-carbonyl)-1,2,4-oxadiazol-3-yl]-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F486-0691

Molecular Formula

C17H15FN6O5 (C17 H15 FN6 O5)

Compound Name

2-(4-fluorophenyl)-4-methyl-6-[5-(morpholine-4-carbonyl)-1,2,4-oxadiazol-3-yl]-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

IUPAC name

2-(4-fluorophenyl)-4-methyl-6-[5-(morpholine-4-carbonyl)-124-oxadiazol-3-yl]-2345-tetrahydro-124-triazine-35-dione

SMILES

CN(C(C(c1noc(C(N2CCOCC2)=O)n1)=NN1c(cc2)ccc2F)=O)C1=O

InChI

InChI=1S/C17H15FN6O5/c1-22-15(25)12(20-24(17(22)27)11-4-2-10(18)3-5-11)13-19-14(29-21-13)16(26)23-6-8-28-9-7-23/h2-5H,6-9H2,1H3

InChI Key

YWLZFLCNYHPLOU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27134073

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

402.34

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

0.798

Distribution Coefficient, logD

0.798

Water Solubility, LogSw

-1.31

Polar Surface Area

98.516

Acid Dissociation Constant (pKa)

29.10

Base Dissociation Constant (pKb)

-1.70

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.40

F486-0691 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F486-0691 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F486-0691?
Check Price and Availability of F486-0691, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F486-0691 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F486-0691
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F486-0691
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F486-0691 available by request